<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OPINION STATEMENT: Management of <z:hpo ids='HP_0001649'>tachycardia</z:hpo> in children depends on the accurate characterization of the origin and mechanism of the rhythm, which can usually be achieved using noninvasive tests such as an electrocardiogram, Holter or cardiac event monitoring </plain></SENT>
<SENT sid="1" pm="."><plain><z:hpo ids='HP_0004755'>Supraventricular tachycardia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SVT</z:e>), the most common tachyarrhythmia in children, is most often due to an accessory pathway or dual AV nodal pathways </plain></SENT>
<SENT sid="2" pm="."><plain><z:chebi fb="3" ids="16335">Adenosine</z:chebi> and vagal maneuvers are useful to diagnose and terminate an <z:hpo ids='HP_0011009'>acute</z:hpo> event </plain></SENT>
<SENT sid="3" pm="."><plain>Long-term management options include prophylactic drug therapy (aimed at suppressing the tachyarrhythmia) and catheter ablation </plain></SENT>
<SENT sid="4" pm="."><plain>Ablation for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SVT</z:e> is highly successful with a low complication rate, and is first-line therapy in older patients </plain></SENT>
<SENT sid="5" pm="."><plain><z:hpo ids='HP_0004308'>Ventricular arrhythmias</z:hpo> are fortunately uncommon in children with <z:mpath ids='MPATH_458'>normal</z:mpath> hearts, and are seen primarily in the setting of abnormal myocardium and inherited ion <z:mp ids='MP_0003484'>channel defects</z:mp> </plain></SENT>
<SENT sid="6" pm="."><plain>Management options for ventricular rhythms include drugs, catheter ablation and implantable cardioverter-defibrillators (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICDs</z:e>) </plain></SENT>
<SENT sid="7" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICDs</z:e> are indicated in patients with a risk of <z:hpo ids='HP_0001699'>sudden death</z:hpo> due to an <z:hpo ids='HP_0011675'>arrhythmia</z:hpo> </plain></SENT>
</text></document>